Key Market Indicators
French diagnostic reagent sales are projected to decline to approximately €305 million by 2028, down from €321 million in 2023, marking an average annual decrease of 0.8%. Despite this drop, the French market experienced significant growth of 6.4% annually since 2000. In 2023, France was ranked 10th globally in diagnostic reagent sales, with Austria surpassing it at the €321 million mark. Spain, the United Kingdom, and Finland held the second, third, and fourth positions, respectively. In terms of imports, French diagnostic reagent imports are expected to increase to about $1.65 billion by 2028, up from $1.56 billion in 2023, representing an average annual growth rate of 0.9%. Since 1999, the demand for diagnostic reagents in France has grown at an annual rate of 1.7%. On the export front, French diagnostic reagent exports are forecasted to reach roughly $1.47 billion by 2028, rising from $1.40 billion in 2023, with an average annual growth rate of 0.8%. French supply has seen a consistent annual increase of 0.8% since 1999. In 2023, France ranked 7th in exports, with Ireland taking over at the $1.40 billion mark. Germany, the Netherlands, and the United Kingdom occupied the second, third, and fourth spots in the rankings, respectively.
